Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular mechanisms augmenting resistance to current therapies in clinics among cervical cancer patients
Soumik Das, Achsha Babu, Tamma Medha, et al.
Medical Oncology (2023) Vol. 40, Iss. 5
Open Access | Times Cited: 11

Showing 11 citing articles:

Elucidating the role of tumor-associated ALOX5+ mast cells with transformative function in cervical cancer progression via single-cell RNA sequencing
Fu Zhao, Junjie Hong, Guangyao Zhou, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 14
Can Vaccines Stop Cancer Before It Starts? Assessing the Promise of Prophylactic Immunization Against High-Risk Preneoplastic Lesions
Tamer A. Addissouky, Ibrahim El Tantawy El Sayed, Majeed M. A. Ali, et al.
Journal of Cellular Immunology (2023) Vol. 5, Iss. 4, pp. 127-140
Open Access | Times Cited: 18
In-silico study unveils potential phytocompounds in Andrographis paniculata against E6 protein of the high-risk HPV-16 subtype for cervical cancer therapy
Md. Aminul Islam, Md. Shohel Hossain, Soharth Hasnat, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Development of an mRNA-based therapeutic vaccine mHTV-03E2 for high-risk HPV-related malignancies
Jing Wang, Qixin Wang, Ling Ma, et al.
Molecular Therapy (2024) Vol. 32, Iss. 7, pp. 2340-2356
Closed Access | Times Cited: 3
Knowledge on Human Papillomavirus Infections, Cancer Biology, Immune Interactions, Vaccination Coverage and Common Treatments: A Comprehensive Review
Nika Nikmanesh, SeyedehZahra Hosseini, Fatemehsadat Mirbagheri, et al.
Viral Immunology (2024) Vol. 37, Iss. 5, pp. 221-239
Closed Access | Times Cited: 1
DDOST is associated with tumor immunosuppressive microenvironment in cervical cancer
Jie Mei, Liuliu Pan, Min Huang, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access
Unravelling Potential Mechanisms of Piper retrofractum Vahl. Bioactive Compounds as Cervical Cancer Chemopreventive Agent by Bioinformatic Approach
I Kadek Sindhu Satya Mahindra, Indra Kusuma, Wayan Dianda Sari, et al.
Indonesian Journal of Cancer Chemoprevention (2024) Vol. 15, Iss. 1, pp. 50-50
Open Access
Metabolism and spatial transcription resolved heterogeneity of glutamine metabolism in cervical carcinoma
Qian Liu, Jianqing Zhu, Guzalinuer Abulizi, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access
Bevacizumab increases cisplatin efficacy by inhibiting epithelial–mesenchymal transition via ALDH1 in cervical carcinoma
Na Qu, Zhuo Li, Jing Wei, et al.
International Immunopharmacology (2024) Vol. 145, pp. 113736-113736
Closed Access
The Significance of Aldehyde Dehydrogenase 1 in Cancers
A. Nguyen, Caroline O. Facey, Bruce M. Boman
International Journal of Molecular Sciences (2024) Vol. 26, Iss. 1, pp. 251-251
Open Access
LKB1/STK11 Tumor Suppressor Reduces Angiogenesis by Directly Interacting with VEGFR2 in Tumorigenesis
Seung Bae Rho, Hyun Jung Byun, Boh-Ram Kim, et al.
Biomolecules & Therapeutics (2023) Vol. 31, Iss. 4, pp. 456-465
Open Access | Times Cited: 1
Page 1

Scroll to top